SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19) in infected individuals, who can either exhibit mild symptoms or progress toward a life-threatening acute respiratory distress syndrome (ARDS). Exacerbated inflammation and dysregulated immune responses involving T and myeloid cells occur in COVID-19 patients with severe clinical progression. However, the differential contribution of specific subsets of dendritic cells and monocytes to ARDS is still poorly understood. In addition, the role of CD8+ T cells present in the lung of COVID-19 patients and relevant for viral control has not been characterized. Here, we have studied the frequencies and activation profiles of dendritic cells and monocytes present in the blood and lung of COVID-19 patients with different clinical severity in comparison with healthy individuals. Furthermore, these subpopulations and their association with antiviral effector CD8+ T cell subsets were also characterized in lung infiltrates from critical COVID-19 patients. Our results indicate that inflammatory transitional and nonclassical monocytes and CD1c+ conventional dendritic cells preferentially migrate from blood to lungs in patients with severe COVID-19. Thus, this study increases the knowledge of specific myeloid subsets involved in the pathogenesis of COVID-19 disease and could be useful for the design of therapeutic strategies for fighting SARS-CoV-2 infection.
Ildefonso Sánchez-Cerrillo, Pedro Landete, Beatriz Aldave, Santiago Sánchez-Alonso, Ana Sánchez-Azofra, Ana Marcos-Jiménez, Elena Ávalos, Ana Alcaraz-Serna, Ignacio de los Santos, Tamara Mateu-Albero, Laura Esparcia, Celia López-Sanz, Pedro Martínez-Fleta, Ligia Gabrie, Luciana del Campo Guerola, Hortensia de la Fuente, María J. Calzada, Isidoro González-Álvaro, Arantzazu Alfranca, Francisco Sánchez-Madrid, Cecilia Muñoz-Calleja, Joan B. Soriano, Julio Ancochea, Enrique Martín-Gayo, the REINMUN-COVID and EDEPIMIC groups
Title and authors | Publication | Year |
---|---|---|
Mucosal immune response in biology, disease prevention and treatment
Zhou X, Wu Y, Zhu Z, Lu C, Zhang C, Zeng L, Xie F, Zhang L, Zhou F |
Signal Transduction and Targeted Therapy | 2025 |
Fu Tu Sheng Jin Rehabilitation Formula Mitigate Airway Inflammation, Mucus Secretion and Immune Dysfunction Induced by SARS-CoV-2 Spike Protein
Wang BH, Yu KY, Zhang XN, Sun XH, Tang LL, Shi XL |
Journal of Inflammation Research | 2025 |
Decreased levels and function of dendritic cells in blood and airways predict COVID‐19 severity
Österberg B, Falck\u2010Jones S, Vangeti S, Åhlberg E, Yu M, Granja D, Snik ME, Falck\u2010Jones R, Barros GW, Charles A, Lepzien R, Johansson N, Holmes TH, Maecker H, Czarnewski P, Bell M, Färnert A, Smed\u2010Sörensen A |
Clinical & Translational Immunology | 2025 |
Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Rodriguez LI, Amadio R, Piperno GM, Benvenuti F |
Journal for Immunotherapy of Cancer | 2025 |
Immunophenotyping of bronchoalveolar lavage and functional impairment in post-COVID syndrome : Insights from a prospective cohort trial.
Gysan MR, Lehmann A, Bernitzky D, Zech A, Brugger J, Prosch H, Idzko M, Gompelmann D |
Wiener klinische Wochenschrift | 2025 |
The underlying mechanism behind the different outcomes of COVID-19 in children and adults.
Shang Z, Huang L, Qin S |
Frontiers in immunology | 2025 |
Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease
Geoffrey Garcia, Sylvie Labrouche-Colomer, Alexandre Duvignaud, Etienne Clequin, Charles Dussiau, David-Alexandre Trégouët, Denis Malvy, Renaud Prevel, Atika Zouine, Isabelle Pellegrin, Julien Goret, Maria Mamani-Matsuda, Antoine Dewitte, Chloe James |
Journal of Translational Medicine | 2024 |
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity.
Lin QXX, Rajagopalan D, Gamage AM, Tan LM, Venkatesh PN, Chan WOY, Kumar D, Agrawal R, Chen Y, Fong SW, Singh A, Sun LJ, Tan SY, Chai LYA, Somani J, Lee B, Renia L, Ng LFP, Ramanathan K, Wang LF, Young B, Lye D, Singhal A, Prabhakar S |
Nature Communications | 2024 |
SiFT: uncovering hidden biological processes by probabilistic filtering of single-cell data.
Piran Z, Nitzan M |
Nature Communications | 2024 |
Acellular Human Amniotic Fluid-Derived Extracellular Vesicles as Novel Anti-Inflammatory Therapeutics against SARS-CoV-2 Infection
Chanda D, Del Rivero T, Ghimire R, More S, Mitrani MI, Bellio MA, Channappanavar R |
Viruses | 2024 |
Persisting IL-18 levels after COVID-19 correlate with markers of cardiovascular inflammation reflecting potential risk of CVDs development.
Andrejčinová I, Blažková G, Papatheodorou I, Bendíčková K, Bosáková V, Skotáková M, Panovský R, Opatřil L, Vymazal O, Kovačovicová P, Šrámek V, Helán M, Hortová-Kohoutková M, Frič J |
Heliyon | 2024 |
SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.
Manfrini N, Notarbartolo S, Grifantini R, Pesce E |
2024 | |
NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins.
Tsukalov I, Sánchez-Cerrillo I, Rajas O, Avalos E, Iturricastillo G, Esparcia L, Buzón MJ, Genescà M, Scagnetti C, Popova O, Martin-Cófreces N, Calvet-Mirabent M, Marcos-Jimenez A, Martínez-Fleta P, Delgado-Arévalo C, de Los Santos I, Muñoz-Calleja C, Calzada MJ, González Álvaro I, Palacios-Calvo J, Alfranca A, Ancochea J, Sánchez-Madrid F, Martin-Gayo E |
Nature Communications | 2024 |
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2
Opsteen S, Fram T, Files JK, Levitan EB, Goepfert P, Erdmann N |
Journal of acquired immune deficiency syndromes (1999) | 2024 |
Impact of an Injectable Trace Mineral Supplement on the Immune Response and Outcome of Mannheimia haemolytica Infection in Feedlot Cattle.
Hong S, Rients EL, Franco CE, Hansen SL, McGill JL |
Biological trace element research | 2024 |
Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis
Zhu R, Zhao Y, Yin H, Shu L, Ma Y, Tao Y |
Scientific Reports | 2024 |
Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease
Meggyes M, Nagy DU, Toth I, Feik T, Peterfalvi A, Polgar B, Sipos D, Kemeny A, Szereday L |
Frontiers in Microbiology | 2024 |
The Complex Immune Cell Composition and Cellular Interaction in the Alveolar Compartment of Patients with Acute Respiratory Distress Syndrome
Zhang S, Duitman J, Artigas A, Bos LD |
American Journal of Respiratory Cell and Molecular Biology | 2024 |
The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine storm
Matthias Hamdorf, Thomas Imhof, Ben Bailey-Elkin, Janina Betz, Sebastian J. Theobald, Alexander Simonis, Veronica Cristanziano, Lutz Gieselmann, Felix Dewald, Clara Lehmann, Max Augustin, Florian Klein, Miguel Alcazar, Robert Rongisch, Mario Fabri, Jan Rybniker, Jörg Stetefeld, Bent Brachvoge, Claus Cursiefen, Manuel Koch, Felix Bock |
Journal of Molecular Cell Biology | 2023 |
Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
Wigerblad G, Warner SA, Ramos-Benitez MJ, Kardava L, Tian X, Miao R, Reger R, Chakraborty M, Wong S, Kanthi Y, Suffredini AF, Dell\u2019Orso S, Brooks S, King C, Shlobin O, Nathan SD, Cohen J, Moir S, Childs RW, Kaplan MJ, Chertow DS, Strich JR |
Science Advances | 2023 |
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Hopkins FR, Govender M, Svanberg C, Nordgren J, Waller H, Nilsdotter-Augustinsson Å, Henningsson AJ, Hagbom M, Sjöwall J, Nyström S, Larsson M |
Frontiers in immunology | 2023 |
Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients
González-Cuadrado C, Caro-Espada PJ, Chivite-Lacaba M, Utrero-Rico A, Lozano-Yuste C, Gutierrez-Solis E, Morales E, Sandino-Pérez J, Gil-Etayo FJ, Allende-Martínez L, Laguna-Goya R, Paz-Artal E |
International journal of molecular sciences | 2023 |
CD1C is associated with breast cancer prognosis and immune infiltrates
Chen X, Zhang J, Lei X, Yang L, Li W, Zheng L, Zhang S, Ding Y, Shi J, Zhang L, Li J, Tang T, Jia W |
BMC Cancer | 2023 |
Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
Santinelli L, Lazzaro A, Sciarra F, Maddaloni L, Frasca F, Fracella M, Moretti S, Borsetti A, Bugani G, Alessandri F, Zullino V, Ruberto F, Pugliese F, Sorrentino L, Gianfrilli D, Isidori A, Venneri MA, Mastroianni CM, Ceccarelli G, d\u2019Ettorre G |
Pathogens | 2023 |
Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence
Filippatos F, Tatsi EB, Michos A |
International journal of molecular sciences | 2023 |
Neutrophils in Health and Disease: From Receptor Sensing to Inflammasome Activation.
Iwaniuk A, Jablonska E |
International journal of molecular sciences | 2023 |
Mycobacterium manresensis induces trained immunity in vitro
de Homdedeu M, Sanchez-Moral L, Violán C, Ràfols N, Ouchi D, Martín B, Peinado MA, Rodríguez-Cortés A, Arch-Sisquella M, Perez-Zsolt D, Muñoz-Basagoiti J, Izquierdo-Useros N, Salvador B, Matllo J, López-Serrano S, Segalés J, Vilaplana C, Torán-Monserrat P, Morros R, Monfà R, Sarrias MR, Cardona PJ |
iScience | 2023 |
Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients
Sun R, Cai Y, Zhou Y, Bai G, Zhu A, Kong P, Sun J, Li Y, Liu Y, Liao W, Liu J, Cui N, Xiang J, Li B, Zhao J, Wu D, Ran P |
Frontiers in immunology | 2023 |
Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study
Vazquez-Alejo E, Tarancon-Diez L, Espinar-Buitrago MD, Genebat M, Calderón A, Pérez-Cabeza G, Magro-Lopez E, Leal M, Muñoz-Fernández MÁ |
Journal of Clinical Medicine | 2023 |
Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets.
Luo H, Chen J, Jiang Q, Yu Y, Yang M, Luo Y, Wang X |
Clinical Epigenetics | 2023 |
Cell and cytokine analyses from bronchoalveolar lavage in non-critical COVID-19 pneumonia.
Rolland-Debord C, Piéroni L, Bejar F, Milon A, Choinier P, Blin E, Bravais J, Halitim P, Letellier A, Camuset J, Parrot A, Fajac A, Cadranel J |
Internal and Emergency Medicine | 2023 |
Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases
Nguyen HO, Tiberio L, Facchinetti F, Ripari G, Violi V, Villetti G, Salvi V, Bosisio D |
Pharmaceutics | 2023 |
Single-cell RNA Sequencing Reveals Novel Cellular Factors for Response to Immunosuppressive Therapy in Aplastic Anemia
Jang J, Kim H, Park SS, Kim M, Min YK, Jeong HO, Kim S, Hwang T, Choi DW, Kim HJ, Song S, Kim DO, Lee S, Lee CH, Lee JW |
HemaSphere | 2023 |
Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney
Miguel V, Rey-Serra C, Tituaña J, Sirera B, Alcalde-Estévez E, Herrero JI, Ranz I, Fernández L, Castillo C, Sevilla L, Nagai J, Reimer KC, Jansen J, Kramann R, Costa IG, Castro A, Sancho D, Rodríguez González-Moro JM, Lamas S |
Redox Biology | 2023 |
Single‐cell transcriptomic atlas of distinct early immune responses induced by SARS‐CoV‐2 Proto or its variants in rhesus monkey
Yang Y, Du T, Yu W, Zhou Y, Yang C, Kuang D, Wang J, Tang C, Wang H, Zhao Y, Yang H, Huang Q, Wu D, Li B, Sun Q, Liu H, Lu S, Peng X |
2023 | |
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
Giulia Lamacchia, Alessio Mazzoni, Michele Spinicci, Anna Vanni, Lorenzo Salvati, Benedetta Peruzzi, Sara Bencini, Manuela Capone, Alberto Carnasciali, Parham Farahvachi, Arianna Rocca, Seble Kiros, Lucia Graziani, Lorenzo Zammarchi, Jessica Mencarini, Maria Colao, Roberto Caporale, Francesco Liotta, Lorenzo Cosmi, Gian Rossolini, Alessandro Bartoloni, Laura Maggi, Francesco Annunziato |
2022 | |
Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection
T Chang, J Yang, H Deng, D Chen, X Yang, Z Tang |
Frontiers in immunology | 2022 |
Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection
N Albayrak, C Cano, S Karimi, D Dogahe, A Praet, A Godefroid, V Marmol, D Grimaldi, B Bondue, J Vooren, F Mascart, V Corbière |
Frontiers in immunology | 2022 |
The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs
H Nguyen, T Schioppa, L Tiberio, F Facchinetti, G Villetti, M Civelli, A Prete, F Sozio, C Gaudenzi, M Passari, I Barbazza, S Sozzani, V Salvi, D Bosisio |
Frontiers in immunology | 2022 |
Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function
E Ahmadi, Z Bagherpour, E Zarei, A Omidkhoda |
Pathology, research and practice | 2022 |
Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
K Nagaoka, H Kawasuji, Y Murai, M Kaneda, A Ueno, Y Miyajima, Y Fukui, Y Morinaga, Y Yamamoto |
Frontiers in immunology | 2022 |
Multiscale PHATE identifies multimodal signatures of COVID-19
M Kuchroo, J Huang, P Wong, J Grenier, D Shung, A Tong, C Lucas, J Klein, D Burkhardt, S Gigante, A Godavarthi, B Rieck, B Israelow, M Simonov, T Mao, J Oh, J Silva, T Takahashi, C Odio, A Casanovas-Massana, J Fournier, A Obaid, A Moore, A Lu-Culligan, A Nelson, A Brito, A Nunez, A Martin, A Wyllie, A Watkins, A Park, A Venkataraman, B Geng, C Kalinich, C Vogels, C Harden, C Todeasa, C Jensen, D Kim, D McDonald, D Shepard, E Courchaine, E White, E Song, E Silva, E Kudo, G DeIuliis, H Wang, H Rahming, H Park, I Matos, I Ott, J Nouws, J Valdez, J Fauver, J Lim, K Rose, K Anastasio, K Brower, L Glick, L Sharma, L Sewanan, L Knaggs, M Minasyan, M Batsu, M Tokuyama, M Muenker, M Petrone, M Kuang, M Nakahata, M Campbell, M Linehan, M Askenase, M Simonov, M Smolgovsky, N Grubaugh, N Sonnert, N Naushad, P Vijayakumar, P Lu, R Earnest, R Martinello, R Herbst, R Datta, R Handoko, S Bermejo, S Lapidus, S Prophet, S Bickerton, S Velazquez, S Mohanty, T Alpert, T Rice, W Schulz, W Khoury-Hanold, X Peng, Y Yang, Y Cao, Y Strong, S Farhadian, C Cruz, A Ko, M Hirn, F Wilson, J Hussin, G Wolf, A Iwasaki, S Krishnaswamy |
Nature Biotechnology | 2022 |
Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence
G Papadopoulou, E Manoloudi, N Repousi, L Skoura, T Hurst, T Karamitros |
Pathogens | 2022 |
Inflammasome activation in neutrophils of patients with severe COVID-19
K Aymonnier, J Ng, L Fredenburgh, K Zambrano-Vera, P Münzer, S Gutch, S Fukui, M Desjardins, M Subramaniam, R Baron, B Raby, M Perrella, J Lederer, D Wagner |
Blood Advances | 2022 |
Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?
A Costanza, A Amerio, A Aguglia, G Serafini, M Amore, R Hasler, J Ambrosetti, G Bondolfi, G Sampogna, I Berardelli, A Fiorillo, M Pompili, K Nguyen |
Neuroscience and biobehavioral reviews | 2022 |
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
S Chakraborty, J Gonzalez, B Sievers, V Mallajosyula, S Chakraborty, M Dubey, U Ashraf, B Cheng, N Kathale, K Tran, C Scallan, A Sinnott, A Cassidy, S Chen, T Gelbart, F Gao, Y Golan, X Ji, S Kim-Schulze, M Prahl, S Gaw, S Gnjatic, T Marron, M Merad, P Arunachalam, S Boyd, M Davis, M Holubar, C Khosla, H Maecker, Y Maldonado, E Mellins, K Nadeau, B Pulendran, U Singh, A Subramanian, P Utz, R Sherwood, S Zhang, P Jagannathan, G Tan, T Wang |
Science Translational Medicine | 2022 |
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
A Shafqat, S Shafqat, S Salameh, J Kashir, K Alkattan, A Yaqinuddin |
Frontiers in immunology | 2022 |
Intermediate Monocytes with PD-L1 and CD62L Expression as a Possible Player in Active SARS-CoV-2 Infection
E Rutkowska, I Kwiecień, K Kłos, P Rzepecki, A Chciałowski |
Viruses | 2022 |
Deuterated Arachidonic Acid Ameliorates Lipopolysaccharide-Induced Lung Damage in Mice
A Molchanova, S Rjabceva, T Melik-Kasumov, N Pestov, P Angelova, V Shmanai, O Sharko, A Bekish, G James, H Park, I Udalova, J Brenna, M Shchepinov |
Antioxidants | 2022 |
The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
Gupta GS |
Inflammation | 2022 |
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Rovito R, Augello M, Ben-Haim A, Bono V, d\u2019Arminio Monforte A, Marchetti G |
Frontiers in immunology | 2022 |
Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation
Wu H, He P, Ren Y, Xiao S, Wang W, Liu Z, Li H, Wang Z, Zhang D, Cai J, Zhou X, Jiang D, Fei X, Zhao L, Zhang H, Liu Z, Chen R, Li W, Wang C, Zhang S, Qin J, Nashan B, Sun C |
Nature Communications | 2022 |
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
Zhang W, Chua BY, Selva KJ, Kedzierski L, Ashhurst TM, Haycroft ER, Shoffner-Beck SK, Hensen L, Boyd DF, James F, Mouhtouris E, Kwong JC, Chua KY, Drewett G, Copaescu A, Dobson JE, Rowntree LC, Habel JR, Allen LF, Koay HF, Neil JA, Gartner MJ, Lee CY, Andersson P, Khan SF, Blakeway L, Wisniewski J, McMahon JH, Vine EE, Cunningham AL, Audsley J, Thevarajan I, Seemann T, Sherry NL, Amanat F, Krammer F, Londrigan SL, Wakim LM, King NJ, Godfrey DI, Mackay LK, Thomas PG, Nicholson S, Arnold KB, Chung AW, Holmes NE, Smibert OC, Trubiano JA, Gordon CL, Nguyen TH, Kedzierska K |
Nature Communications | 2022 |
Innate and adaptive immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people
Joana Vitallé, Alberto Pérez-Gómez, Francisco Ostos, Carmen Gasca-Capote, M. Reyes Jiménez-Leon, Sara Bachiller, Inmaculada Rivas-Jeremías, Maria del Mar Silva-Sánchez, Anabel M Ruiz-Mateos, María Martín-Sánchez, Luis Fernando López-Cortes, Mohammed Rafii El Idrissi Benhnia, Ezequiel Ruiz-Mateos |
JCI Insight | 2022 |
Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality
Budhraja A, Basu A, Gheware A, Abhilash D, Rajagopala S, Pakala S, Sumit M, Ray A, Subramaniam A, Mathur P, Nambirajan A, Kumar S, Gupta R, Wig N, Trikha A, Guleria R, Sarkar C, Gupta I, Jain D |
Disease models & mechanisms | 2022 |
Immune Senescence, Immunosenescence and Aging
Lee KA, Flores RR, Jang IH, Saathoff A, Robbins PD |
2022 | |
Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
Van der Sluis RM, Holm CK, Jakobsen MR |
Cell Reports | 2022 |
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
Trujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Fernández JM, Pérez-Gómez A, Gasca-Capote C, Vitallé J, Peraire J, Palacios-Baena ZR, Cabrera JJ, Ruiz-Mateos E, Poveda E, López-Cortés LE, Rull A, Gutierrez-Valencia A, López-Cortés LF |
PloS one | 2022 |
Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
Byeon SK, Madugundu AK, Garapati K, Ramarajan MG, Saraswat M, Kumar-M P, Hughes T, Shah R, Patnaik MM, Chia N, Ashrafzadeh-Kian S, Yao JD, Pritt BS, Cattaneo R, Salama ME, Zenka RM, Kipp BR, Grebe SKG, Singh RJ, Sadighi Akha AA, Algeciras-Schimnich A, Dasari S, Olson JE, Walsh JR, Venkatakrishnan AJ, Jenkinson G, O'Horo JC, Badley AD, Pandey A |
2022 | |
Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine
Al-Attiyah R, Safar HA, Botras L, Botras M, Al-Kandari F, Chehadeh W, Mustafa AS |
Frontiers in immunology | 2022 |
Single‐cell immune profiling reveals long‐term changes in myeloid cells and identifies a novel subset of CD9+ monocytes associated with COVID‐19 hospitalization
Pandori WJ, Padgett LE, Alimadadi A, Gutierrez NA, Araujo DJ, Huh CJ, Olingy CE, Dinh HQ, Wu R, Vijayanand P, Chee SJ, Ottensmeier CH, Hedrick CC |
Journal of leukocyte biology | 2022 |
Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
Kudryavtsev IV, Arsentieva NA, Korobova ZR, Isakov DV, Rubinstein AA, Batsunov OK, Khamitova IV, Kuznetsova RN, Savin TV, Akisheva TV, Stanevich OV, Lebedeva AA, Vorobyov EA, Vorobyova SV, Kulikov AN, Sharapova MA, Pevtsov DE, Totolian AA |
Viruses | 2022 |
Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Bencze D, Fekete T, Pázmándi K |
International journal of molecular sciences | 2022 |
Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19
Hastak PS, Andersen CR, Kelleher AD, Sasson SC |
Frontiers in immunology | 2022 |
Respiratory and systemic monocytes, dendritic cells, and myeloid‐derived suppressor cells in COVID‐19: Implications for disease severity
Falck\u2010Jones S, Österberg B, Smed\u2010Sörensen A |
Journal of Internal Medicine | 2022 |
Tissue-resident immunity in the lung: a first-line defense at the environmental interface.
Zazara DE, Belios I, Lücke J, Zhang T, Giannou AD |
Seminars in Immunopathology | 2022 |
Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals.
Rajamanickam A, Kumar NP, Pandiaraj AN, Selvaraj N, Munisankar S, Renji RM, Venkatramani V, Murhekar M, Thangaraj JWV, Kumar MS, Kumar CPG, Bhatnagar T, Ponnaiah M, Sabarinathan R, Saravanakumar V, Babu S |
BMC Immunology | 2022 |
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
Tizazu AM, Mengist HM, Demeke G |
Immunity & ageing : I & A | 2022 |
Routine hematology parameters in COVID-19: A predictor of disease severity and mortality
Awale RB, Singh A, Mishra P, Bais PS, Vansh K, Shamim R, Ghatak T, Hashim Z, Gupta D, Nath A, Singh RK, Singh C, Pande S |
Journal of Family Medicine and Primary Care | 2022 |
Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity
Mi Y, Liang L, Xu K, Li Q, Wang W, Dang W, Deng J, Zhi Y, Li X, Tan J |
Frontiers in Cellular and Infection Microbiology | 2022 |
The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases
Shi X, Zhou H, Wei J, Mo W, Li Q, Lv X |
Redox Biology | 2022 |
Cellular immune states in SARS-CoV-2-induced disease
Mortezaee K, Majidpoor J |
Frontiers in immunology | 2022 |
Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection
Cords L, Woost R, Kummer S, Brehm TT, Kluge S, Schmiedel S, Jordan S, Lohse AW, Altfeld M, Addo MM, Schulze zur Wiesch J, Beisel C |
Cytokine | 2022 |
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
Gisby JS, Buang NB, Papadaki A, Clarke CL, Malik TH, Medjeral-Thomas N, Pinheiro D, Mortimer PM, Lewis S, Sandhu E, McAdoo SP, Prendecki MF, Willicombe M, Pickering MC, Botto M, Thomas DC, Peters JE |
Nature Communications | 2022 |
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae.
Thompson RC, Simons NW, Wilkins L, Cheng E, Del Valle DM, Hoffman GE, Cervia C, Fennessy B, Mouskas K, Francoeur NJ, Johnson JS, Lepow L, Le Berichel J, Chang C, Beckmann AG, Wang YC, Nie K, Zaki N, Tuballes K, Barcessat V, Cedillo MA, Yuan D, Huckins L, Roussos P, Marron TU, Glicksberg BS, Nadkarni G, Heath JR, Gonzalez-Kozlova E, Boyman O, Kim-Schulze S, Sebra R, Merad M, Gnjatic S, Schadt EE, Charney AW, Beckmann ND |
Nature Medicine | 2022 |
Flavanol Consumption in Healthy Men Preserves Integrity of Immunological-Endothelial Barrier Cell Functions: Nutri(epi)genomic Analysis.
Milenkovic D, Rodriguez-Mateos A, Lucosz M, Istas G, Declerck K, Sansone R, Deenen R, Köhrer K, Corral-Jara KF, Altschmied J, Haendeler J, Kelm M, Berghe WV, Heiss C |
Molecular Nutrition & Food Research | 2022 |
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
Laurent P, Yang C, Rendeiro AF, Nilsson-Payant BE, Carrau L, Chandar V, Bram Y, tenOever BR, Elemento O, Ivashkiv LB, Schwartz RE, Barrat FJ |
Science Immunology | 2022 |
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients
G Riva, S Castellano, V Nasillo, AM Ottomano, G Bergonzini, A Paolini, B Lusenti, J Milić, SD Biasi, L Gibellini, A Cossarizza, S Busani, M Girardis, G Guaraldi, C Mussini, R Manfredini, M Luppi, E Tagliafico, T Trenti |
Scientific Reports | 2021 |
Impaired function and delayed regeneration of dendritic cells in COVID-19
E Winheim, L Rinke, K Lutz, A Reischer, A Leutbecher, L Wolfram, L Rausch, J Kranich, PR Wratil, JE Huber, D Baumjohann, S Rothenfusser, B Schubert, A Hilgendorff, JC Hellmuth, C Scherer, M Muenchhoff, M von Bergwelt-Baildon, K Stark, T Straub, T Brocker, OT Keppler, M Subklewe, AB Krug, M Suthar |
PLoS pathogens | 2021 |
T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
O Zenarruzabeitia, G Astarloa-Pando, I Terrén, A Orrantia, R Pérez-Garay, I Seijas-Betolaza, J Nieto-Arana, N Imaz-Ayo, S Pérez-Fernández, E Arana-Arri, F Borrego |
Frontiers in immunology | 2021 |
Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys
C Coleman, LA Doyle-Meyers, KE Russell-Lodrigue, N Golden, B Threeton, K Song, G Pierre, C Baribault, RP Bohm, NJ Maness, JK Kolls, J Rappaport, JC Mudd |
Frontiers in immunology | 2021 |
Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019
F Qi, W Zhang, J Huang, L Fu, J Zhao |
Frontiers in immunology | 2021 |
Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape
K Mukund, P Nayak, C Ashokkumar, S Rao, J Almeda, MM Betancourt-Garcia, R Sindhi, S Subramaniam |
Frontiers in immunology | 2021 |
Aging versus youth: Endocrine aspects of vulnerability for COVID-19
SH Oguz, M Koca, BO Yildiz |
Reviews in Endocrine and Metabolic Disorders | 2021 |
Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
A Paolini, R Borella, SD Biasi, A Neroni, M Mattioli, DL Tartaro, C Simonini, L Franceschini, G Cicco, AM Piparo, A Cossarizza, L Gibellini |
Cells | 2021 |
Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype
AC Trombetta, GB Farias, AM Gomes, A Godinho-Santos, P Rosmaninho, CM Conceição, J Laia, DF Santos, AR Almeida, C Mota, A Gomes, M Serrano, M Veldhoen, AE Sousa, SM Fernandes |
Frontiers in immunology | 2021 |
Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers
V Seery, SC Raiden, SC Algieri, NA Grisolía, D Filippo, ND Carli, SD Lalla, H Cairoli, MJ Chiolo, CN Meregalli, LI Gimenez, G Gregorio, M Sarli, AL Alcalde, C Davenport, MJ Bruera, N Simaz, MF Pérez, V Nivela, C Bayle, P Tuccillo, MT Agosta, H Pérez, SV Nova, P Suárez, EM Takata, M García, J Lattner, MJ Rolón, P Coll, I Sananez, MP Holgado, F Ferrero, J Geffner, L Arruvito |
EBioMedicine | 2021 |
A hitchhiker's guide through the COVID-19 galaxy
S Felsenstein, AO Reiff |
Clinical Immunology | 2021 |
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
SR Dyavar, R Singh, R Emani, GP Pawar, VD Chaudhari, AT Podany, SN Avedissian, CV Fletcher, DB Salunke |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
X Wang, P Yi, Y Liang |
Frontiers in immunology | 2021 |
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
A MarcosJiménez, S SánchezAlonso, A AlcarazSerna, L Esparcia, C LópezSanz, M SampedroNúñez, T MateuAlbero, I SánchezCerrillo, P MartínezFleta, L Gabrie, LC Guerola, JM RodríguezFrade, JM Casasnovas, HT Reyburn, M ValésGómez, M LópezTrascasa, E MartínGayo, MJ Calzada, S Castañeda, H Fuente, I GonzálezÁlvaro, F SánchezMadrid, C MuñozCalleja, A Alfranca |
European Journal of Immunology | 2021 |
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, H Jang, Y Huang, JD Allen, JB Case, RE Sutton, RH Carnahan, TL Darling, AC Boon, M Mack, RD Head, TM Ross, JE Crowe, MS Diamond |
Cell | 2021 |
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice
TR Karhadkar, D Pilling, RH Gomer, H Fehrenbach |
PloS one | 2021 |
A bird's eye view on the role of dendritic cells in SARS‐CoV‐2 infection: Perspectives for immune‐based vaccines
D Galati, S Zanotta, L Capitelli, M Bocchino |
Allergy | 2021 |
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
C Liu, AJ Martins, WW Lau, N Rachmaninoff, J Chen, L Imberti, D Mostaghimi, DL Fink, PD Burbelo, K Dobbs, OM Delmonte, N Bansal, L Failla, A Sottini, E Quiros-Roldan, KL Han, BA Sellers, F Cheung, R Sparks, TW Chun, S Moir, MS Lionakis, C Rossi, HC Su, DB Kuhns, JI Cohen, LD Notarangelo, JS Tsang, MS Abers, R Apps, M Bosticardo, P Milanez-Almeida, MP Mulè, E Shaw, Y Zhang, F Castelli, ML Muiesan, G Tomasoni, F Scolari, A Tucci |
Cell | 2021 |
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing
L Marongiu, G Protti, FA Facchini, M Valache, F Mingozzi, V Ranzani, AR Putignano, L Salviati, V Bevilacqua, S Curti, M Crosti, ML Sarnicola, M D'Angiò, LR Bettini, A Biondi, L Nespoli, N Tamini, N Clementi, N Mancini, S Abrignani, R Spreafico, F Granucci |
European Journal of Immunology | 2021 |
Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19
V Chilunda, P Martinez-Aguado, LC Xia, L Cheney, A Murphy, V Veksler, V Ruiz, TM Calderon, JW Berman |
Frontiers in immunology | 2021 |
Monocytes and Macrophages in COVID-19
R Knoll, JL Schultze, J Schulte-Schrepping |
Frontiers in immunology | 2021 |
SARS‐CoV‐2 sculpts the immune system to induce sustained virus‐specific naïve‐like and memory B‐cell responses
L de CamposMata, ST Vaquero, R TachóPiñot, J Piñero, EK Grasset, IA Aldea, NR Melero, C Carolis, JP Horcajada, A Cerutti, J VillarGarcía, G Magri |
IBMS BoneKEy | 2021 |
COVID-19 illness and autoimmune diseases: recent insights
J Li, HH Liu, XD Yin, CC Li, J Wang |
Inflammation Research | 2021 |
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
A Mazzoni, L Salvati, L Maggi, F Annunziato, L Cosmi |
Seminars in Immunology | 2021 |
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, G Lachmann, G Monneret, F Venet, M Bauer, FM Brunkhorst, S Weis, A Garcia-Salido, M Kox, JM Cavaillon, F Uhle, MA Weigand, SB Flohé, WJ Wiersinga, R Almansa, A de la Fuente, I Martin-Loeches, C Meisel, T Spinetti, JC Schefold, C Cilloniz, A Torres, EJ Giamarellos-Bourboulis, R Ferrer, M Girardis, A Cossarizza, MG Netea, T van der Poll, JF Bermejo-Martín, I Rubio |
The lancet. Respiratory medicine | 2021 |
Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals
J Lim, KJ Puan, LW Wang, KW Teng, CY Loh, KP Tan, G Carissimo, YH Chan, CM Poh, CY Lee, SW Fong, NK Yeo, RS Chee, SN Amrun, ZW Chang, MZ Tay, A Torres-Ruesta, NL Fernandez, W How, AK Andiappan, W Lee, K Duan, SY Tan, G Yan, S Kalimuddin, DC Lye, YS Leo, SW Ong, BE Young, L Renia, LF Ng, B Lee, O Rötzschke |
Frontiers in immunology | 2021 |
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
A Sacconi, CD Vitis, L de Latouliere, S di Martino, FD Nicola, F Goeman, C Mottini, F Paolini, M DAscanio, A Ricci, A Tafuri, P Marchetti, AD Napoli, LD Biase, A Negro, C Napoli, P Anibaldi, V Salvati, D Duffy, B Terrier, M Fanciulli, C Capalbo, S Sciacchitano, G Blandino, G Piaggio, R Mancini, G Ciliberto |
Cell Death and Disease | 2021 |
Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients
DA Rodríguez-Serrano, E Roy-Vallejo, ND Cruz, AM Ramírez, SC Rodríguez-García, N Arevalillo-Fernández, JM Galván-Román, LF García-Rodrigo, L Vega-Piris, MC Llano, DA Méndez, BG de Marcos, JH Santos, AS Azofra, EÁ Pérez-Urria, P Rodriguez-Cortes, L Esparcia, A Marcos-Jimenez, S Sánchez-Alonso, I Llorente, J Soriano, CS Fernández, R García-Vicuña, J Ancochea, J Sanz, C Muñoz-Calleja, R de la Cámara, AC Berlanga, I González-Álvaro, L Cardeñoso, RM Hernández, M Orts, C Figueroa, C Román, A Planas, LD Arganda, PM Vives, GD Nieto, A Cecconi, A Benedicto, AR González, J Jiménez-Borreguero, C del Arco, JM Aguilar, N Villalba, M Negro, E Contreras, A del Rey, C Santiago, M Junquera, R Caminero, FJ Val, S González, M Caño, I López, A von Wernitz, I Guerra, J Sorando, L Chao, MJ Cárdenas, V Espiga, A Pizarro, ÁF Álvarez, B Aguado, J Cannata, J Ortiz, A Morell, E Ramírez, AI Zurriaga, MP Abanades, SR García, TG Aranda, M Ruiz, CM Nieto, JM Serra, F Sánchez-Madrid, I Sánchez-Cerrillo, P Martínez-Fleta, C López-Sanz, L Gabrie, L del Campo Guerola, E Fernández, R Tejedor, PA Haro, MT Genao, BQ Dorado, DJ Jiménez, MA González, P Villamayor, I de los Santos, E Sánchez, F Moldenhauer, P Casado, J Curbelo, A Gutiérrez, A Bautista, NR Giménez, A Fernández, LG Fraile, P Parra, B Moyano, A Barrios, P Gil, IG Polo, DR de Asúa, B Sánchez, C Sáez, M Ciudad, MF Rico, CA Román, EM Rodríguez, D Navas, M del Carmen Cuevas Torresano, DD García, TA Cavero, AG Blanco, MA Chong, AG Cobos, AM Torres, T Alonso, P Landete, J Soriano, C Cisneros, EG Castillo, C Valenzuela, FJ Pérez, RM Girón, J Aspa, C Marcos, E Zamora, G Iturricastillo, MB Mayo, ER Garrido, S Castañeda, C Fernández-Díaz, EG Tomero, NG Castañeda, AM Ortiz, C Valero, M Uriarte, N Montes, IG Sanz, FE Viamontes, JD Valdueza |
Scientific Reports | 2021 |
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology
A Codd, S Hanna, E Compeer, F Richter, E Pring, E Gea-Mallorquí, M Borsa, O Moon, D Scourfield, D Ahern, H Almuttaqi, D Alonzi, A Alrubayyi, G Alsaleh, V Bart, V Batchelor, R Bayliss, D Berthold, J Bezbradica, T Bharuchq, H Borrmann, M Borsa, R Borst, J Brun, S Burnell, L Capitani, A Cavounidis, L Chapman, A Chauveau, L Cifuentes, A Codd, E Compeer, C Coveney, A Cross, S Danielli, L Davies, C Dendrou, S Dimonte, R Durairaj, L Dustin, A Dyer, C Fielding, F Fischer, A Gallimore, S Galloway, A Gammage, E Gea-Mallorquí, A Godkin, S Hanna, C Heuberger, S Hulin-Curtis, F Issa, E Jones, R Jones, K Ladell, S Lauder, K Liddiard, P Ligoxygakis, F Lu, B MacLachlan, S Maleki-Toyserkani, E Mann, A Marzeda, R Matthews, J Mazet, A Milicic, E Mitchell, O Moon, V Nguyen, M O'Hanlon, C Pavillet, D Peppa, A Pires, E Pring, M Quastel, S Reed, J Rehwinkel, N Richmond, F Richter, A Robinson, P Rodrigues, P Sabberwal, A Sami, R Peres, Q Sattentau, B Schonfeldova, D Scourfield, T Selvakumar, F Shepherd, C Shorten, A Simon, A Smith, A Crespo, M Tellier, E Thornton, L Uhl, E van Grinsven, A Wann, R Williams, J Wilson, D Zhou, Z Zhu, A Gallimore, A Milicic |
2021 | |
Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity
Wuji Zhang, Brendon Chua, Kevin Selva, Lukasz Kedzierski, Thomas Ashhurst, Ebene Haycroft, Suzanne Shoffner, Luca Hensen, David Boyd, Fiona James, Effie Mouhtouris, Jason Kwong, Kyra Chua, George Drewett, Ana Copaescu, Julie Dobson, Louise Rowntree, Jennifer Habel, Lilith Allen, Hui-Fern Koay, Jessica Neil, Matthew Gartner, Christina Lee, Patiyan Andersson, Torsten Seemann, Norelle Sherry, Fatima Amanat, Florian Krammer, Sarah Londrigan, Linda Wakim, Nicholas King, Dale Godfrey, Laura Mackay, Paul Thomas, Suellen Nicholson, Kelly Arnold, Amy Chung, Natasha Holmes, Olivia Smibert, Jason Trubiano, Claire Gordon, Thi Nguyen, Katherine Kedzierska |
Research square | 2021 |
Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci
CY Moon, BM Schilder, T Raj, K Huang |
iScience | 2021 |
COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?
CG Gallo, S Fiorino, G Posabella, D Antonacci, A Tropeano, E Pausini, C Pausini, T Guarniero, W Hong, E Giampieri, I Corazza, L Federico, D de Biase, M Zippi, M Zancanaro |
Cytokine | 2021 |
Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells
I Nikitopoulou, D Fanidis, K Ntatsoulis, P Moulos, G Mpekoulis, M Evangelidou, AG Vassiliou, V Dimakopoulou, E Jahaj, S Tsipilis, SE Orfanos, I Dimopoulou, E Angelakis, K Akinosoglou, N Vassilaki, A Tzouvelekis, A Kotanidou, V Aidinis |
International journal of molecular sciences | 2021 |
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
N Bozorgmehr, S Mashhouri, EP Rosero, L Xu, S Shahbaz, W Sligl, M Osman, DJ Kutsogiannis, E MacIntyre, CR ONeil, S Elahi, D Paraskevis |
mBio | 2021 |
Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
RP da Silva, JI Gonçalves, RF Zanin, FB Schuch, AP de Souza |
Frontiers in immunology | 2021 |
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
C Gutmann, K Takov, SA Burnap, B Singh, H Ali, K Theofilatos, E Reed, M Hasman, A Nabeebaccus, M Fish, MJ McPhail, K OGallagher, LE Schmidt, C Cassel, M Rienks, X Yin, G Auzinger, S Napoli, SF Mujib, F Trovato, B Sanderson, B Merrick, U Niazi, M Saqi, K Dimitrakopoulou, R Fernández-Leiro, S Braun, R Kronstein-Wiedemann, KJ Doores, JD Edgeworth, AM Shah, SR Bornstein, T Tonn, AC Hayday, M Giacca, M Shankar-Hari, M Mayr |
Nature Communications | 2021 |
Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery
A Utrero-Rico, C González-Cuadrado, M Chivite-Lacaba, O Cabrera-Marante, R Laguna-Goya, P Almendro-Vazquez, C Díaz-Pedroche, M Ruiz-Ruigómez, A Lalueza, MD Folgueira, E Vázquez, A Quintas, MJ Berges-Buxeda, M Martín-Rodriguez, A Dopazo, A Serrano-Hernández, JM Aguado, E Paz-Artal |
Biomedicines | 2021 |
Coronavirus infection: An immunologists' perspective
JB Sanctis, AH García, D Moreno, M Hajduch |
Scandinavian Journal of Immunology | 2021 |
COVID-19–Associated Acute Respiratory Distress Syndrome
EA Middleton, GA Zimmerman |
Critical Care Clinics | 2021 |
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
E Kvedaraite, L Hertwig, I Sinha, A Ponzetta, IH Myrberg, M Lourda, M Dzidic, M Akber, J Klingström, E Folkesson, JR Muvva, P Chen, S Gredmark-Russ, S Brighenti, A Norrby-Teglund, LI Eriksson, O Rooyackers, S Aleman, K Strålin, HG Ljunggren, F Ginhoux, NK Björkström, JI Henter, M Svensson |
Proceedings of the National Academy of Sciences | 2021 |
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection
M Roussel, J Ferrant, F Reizine, SL Gallou, J Dulong, S Carl, M Lesouhaitier, M Gregoire, N Bescher, C Verdy, M Latour, I Bézier, M Cornic, A Vinit, C Monvoisin, B Sawitzki, S Leonard, S Paul, J Feuillard, R Jeannet, T Daix, VK Tiwari, JM Tadié, M Cogné, K Tarte |
Cell reports. Medicine | 2021 |
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
A Pérez-Gómez, J Vitallé, C Gasca-Capote, A Gutierrez-Valencia, M Trujillo-Rodriguez, A Serna-Gallego, E Muñoz-Muela, M de los Reyes Jiménez-Leon, MR Benhnia, I Rivas-Jeremias, C Sotomayor, C Roca-Oporto, N Espinosa, C Infante-Domínguez, JC Crespo-Rivas, A Fernández-Villar, A Pérez-González, LF López-Cortés, E Poveda, E Ruiz-Mateos, JM Cisneros, S Salto-Alejandre, J Berastegui-Cabrera, P Camacho-Martínez, C Infante-Domínguez, M Carretero-Ledesma, JC Crespo-Rivas, E Márquez, JM Lomas, C Bueno, R Amaya, JA Lepe, J Pachón, E Cordero, J Sánchez-Céspedes, M Aguilar-Guisado, A Aguilera, C Aguilera, T Aldabo-Pallas, V Alfaro-Lara, C Amodeo, J Ampuero, MD Avilés, M Asensio, B Barón-Franco, L Barrera-Pulido, R Bellido-Alba, M Bernabeu-Wittel, C Caballero-Eraso, M Cabrera, E Calderón, J Carbajal-Guerrero, M Cid-Cumplido, Y Corcia-Palomo, J Delgado, A Domínguez-Petit, A Deniz, R Dusseck-Brutus, A Escoresca-Ortega, F Espinosa, N Espinosa, M Espinoza, C Ferrándiz-Millón, M Ferrer, T Ferrer, I Gallego-Texeira, R Gámez-Mancera, E García, H García-Delgado, M García-Gutiérrez, ML Gascón-Castillo, A González-Estrada, D González, C Gómez-González, R González-León, C Grande-Cabrerizo, S Gutiérrez, C Hernández-Quiles, IC Herrera-Melero, M Herrero-Romero, L Jara, C Jiménez-Juan, S Jiménez-Jorge, M Jiménez-Sánchez, J Lanseros-Tenllado, C López, I López, Á López-Barrios, LF López-Cortés, R Luque-Márquez, D Macías-García, G Martín-Gutiérrez, L Martín-Villén, J Molina, A Morillo, MD Navarro-Amuedo, D Nieto-Martín, F Ortega, M Paniagua-García, A Peña-Rodríguez, E Pérez, M Poyato, J Praena-Segovia, R Ríos, C Roca-Oporto, JF Rodríguez, MJ Rodríguez-Hernández, S Rodríguez-Suárez, Á Rodríguez-Villodres, N Romero-Rodríguez, R Ruiz, ZR de Azua, C Salamanca, S Sánchez, VM Sánchez-Montagut, C Sotomayor, AS Benjumea, J Toral |
Cellular and Molecular Immunology | 2021 |
A distinct innate immune signature marks progression from mild to severe COVID-19
S Chevrier, Y Zurbuchen, C Cervia, S Adamo, ME Raeber, N de Souza, S Sivapatham, A Jacobs, E Bachli, A Rudiger, M Stüssi-Helbling, LC Huber, DJ Schaer, J Nilsson, O Boyman, B Bodenmiller |
Cell reports. Medicine | 2021 |
A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections
SC Vick, M Frutoso, F Mair, AJ Konecny, E Greene, CR Wolf, JK Logue, NM Franko, J Boonyaratanakornkit, R Gottardo, JT Schiffer, HY Chu, M Prlic, JM Lund |
Science Advances | 2021 |
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients
PR Tembhare, H Sriram, G Chatterjee, T Khanka, A Gokarn, S Mirgh, A Rajendra, A Chaturvedi, SG Ghogale, N Deshpande, K Girase, K Dalvi, S Rajpal, N Patkar, B Trivedi, A Joshi, V Murthy, N Shetty, S Nair, A More, S Kamtalwar, P Chavan, V Bhat, P Bhat, PG Subramanian, S Gupta, N Khattry |
Immunology and Cell Biology | 2021 |
A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID
A Utrero-Rico, M Ruiz-Ruigómez, R Laguna-Goya, E Arrieta-Ortubay, M Chivite-Lacaba, C González-Cuadrado, A Lalueza, P Almendro-Vazquez, A Serrano, JM Aguado, C Lumbreras, E Paz-Artal |
Biomedicines | 2021 |
Myeloid dysregulation and therapeutic intervention in COVID-19
R Gu, T Mao, Q Lu, TT Su, J Wang |
Seminars in Immunology | 2021 |
Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19
D Reynolds, CV Guillamet, A Day, N Borcherding, RV Guillamet, JA Choreño-Parra, SL House, JA OHalloran, J Zúñiga, AH Ellebedy, DE Byers, PA Mudd |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
Immune response to SARS‐CoV‐2 in children: A review of the current knowledge
F Filippatos, EB Tatsi, A Michos |
2021 | |
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
M Severa, RA Diotti, MP Etna, F Rizzo, S Fiore, D Ricci, M Iannetta, A Sinigaglia, A Lodi, N Mancini, E Criscuolo, M Clementi, M Andreoni, S Balducci, L Barzon, P Stefanelli, N Clementi, EM Coccia, MS Diamond |
PLoS pathogens | 2021 |
Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19
N Nassir, R Tambi, A Bankapur, SA Heialy, N Karuvantevida, HH Khansaheb, B Zehra, G Begum, RA Hameid, A Ahmed, Z Deesi, A Alkhajeh, KM Uddin, H Akter, SA Shabestari, O Almidani, A Islam, M Gaudet, RK Kandasamy, T Loney, AA Tayoun, N Nowotny, M Woodbury-Smith, P Rahman, WM Kuebler, MY Hachim, JL Casanova, BK Berdiev, A Alsheikh-Ali, M Uddin |
iScience | 2021 |
SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon
M Shemesh, TE Aktepe, JM Deerain, JL McAuley, MD Audsley, CT David, DF Purcell, V Urin, R Hartmann, GW Moseley, JM Mackenzie, G Schreiber, D Harari, A Pekosz |
PLoS pathogens | 2021 |
Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns
EE Christensen, MJ Jørgensen, KG Nore, TB Dahl, K Yang, T Ranheim, C Huse, A Lind, S Nur, B Stiksrud, S Jenum, K Tonby, JC Holter, AR Holten, B Halvorsen, AM DyrholRiise |
Journal of Internal Medicine | 2021 |
Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response
A Mithal, AJ Hume, J Lindstrom-Vautrin, C Villacorta-Martin, J Olejnik, E Bullitt, A Hinds, E Mühlberger, G Mostoslavsky |
Stem Cell Reports | 2021 |
Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods
DU Putri, CH Wang, PC Tseng, WS Lee, FL Chen, HP Kuo, CH Lee, CF Lin |
Viruses | 2021 |
High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19.
De Zuani M, Lazničková P, Tomašková V, Dvončová M, Forte G, Stokin GB, Šrámek V, Helán M, Frič J |
Scandinavian Journal of Immunology | 2021 |
A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections.
Vick SC, Frutoso M, Mair F, Konecny AJ, Greene E, Wolf CR, Logue JK, Boonyaratanakornkit J, Gottardo R, Schiffer JT, Chu HY, Prlic M, Lund JM |
medRxiv : the preprint server for health sciences | 2021 |
COVID-19 and myeloid cells: complex interplay correlates with lung severity
Franco R. D'Alessio, Nicola M. Heller |
Journal of Clinical Investigation | 2020 |
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar |
International Immunopharmacology | 2020 |
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
G Carissimo, W Xu, I Kwok, MY Abdad, YH Chan, SW Fong, KJ Puan, CY Lee, NK Yeo, SN Amrun, RS Chee, W How, S Chan, BE Fan, AK Andiappan, B Lee, O Rötzschke, BE Young, YS Leo, DC Lye, L Renia, LG Ng, A Larbi, LF Ng |
Nature Communications | 2020 |
The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection
O Gallo, LG Locatello, A Mazzoni, L Novelli, F Annunziato |
Mucosal Immunology | 2020 |
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection
B Peruzzi, S Bencini, M Capone, A Mazzoni, L Maggi, L Salvati, A Vanni, C Orazzini, C Nozzoli, A Morettini, L Poggesi, F Pieralli, A Peris, A Bartoloni, AM Vannucchi, F Liotta, R Caporale, L Cosmi, F Annunziato |
Immunology | 2020 |
Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology
PR Rodrigues, A Alrubayyi, E Pring, VM Bart, R Jones, C Coveney, F Lu, M Tellier, S Maleki-Toyserkani, FC Richter, DO Scourfield, E Gea-Mallorquí, LC Davies |
2020 | |
Decrease of Non‐Classical and Intermediate Monocyte Subsets in Severe Acute SARS‐CoV‐2 Infection
Gatti A, Radrizzani D, Viganò P, Mazzone A, Brando B |
Cytometry Part A | 2020 |